MR‐visible lipids and the tumor microenvironment

MR‐visible lipids or mobile lipids are defined as lipids that are observable using proton MRS in cells and tissues. These MR‐visible lipids are composed of triglycerides and cholesterol esters that accumulate in neutral lipid droplets, where their MR visibility is conferred as a result of the increased molecular motion available in this unique physical environment. This review discusses the factors that lead to the biogenesis of MR‐visible lipids in cancer cells and in other cell types, such as immune cells and fibroblasts. We focus on the accumulations of mobile lipids that are inducible in cultured cells by a number of stresses, including culture conditions, and in response to activating stimuli or apoptotic cell death induced by anticancer drugs. This is compared with animal tumor models, where increases in mobile lipids are observed in response to chemo‐ and radiotherapy, and to human tumors, where mobile lipids are observed predominantly in high‐grade brain tumors and in regions of necrosis. Conducive conditions for mobile lipid formation in the tumor microenvironment are discussed, including low pH, oxygen availability and the presence of inflammatory cells. It is concluded that MR‐visible lipids appear in cancer cells and human tumors as a stress response. Mobile lipids stored as neutral lipid droplets may play a role in the detoxification of the cell or act as an alternative energy source, especially in cancer cells, which often grow in ischemic/hypoxic environments. The role of MR‐visible lipids in cancer diagnosis and the assessment of the treatment response in both animal models of cancer and human brain tumors is also discussed. Although technical limitations exist in the accurate detection of intratumoral mobile lipids, early increases in mobile lipids after therapeutic interventions may be useful as a potential biomarker for the assessment of treatment response in cancer. Copyright © 2011 John Wiley & Sons, Ltd.

[1]  Sanjeev Chawla,et al.  Proton Magnetic Resonance Spectroscopy in Differentiating Glioblastomas From Primary Cerebral Lymphomas and Brain Metastases , 2010, Journal of computer assisted tomography.

[2]  Claus Cornett,et al.  A role for taurine in mitochondrial function , 2010, Journal of Biomedical Science.

[3]  Robert J. Gillies,et al.  Tumor pH and Its Measurement , 2010, The Journal of Nuclear Medicine.

[4]  C. Koch,et al.  Early detection of radiation therapy response in non‐Hodgkin's lymphoma xenografts by in vivo 1H magnetic resonance spectroscopy and imaging , 2010, NMR in biomedicine.

[5]  Rolf Gruetter,et al.  Neurochemical profile of the mouse hypothalamus using in vivo 1H MRS at 14.1T , 2010, NMR in biomedicine.

[6]  C. Arús,et al.  13C-labelling studies indicate compartmentalized synthesis of triacylglycerols in C6 rat glioma cells. , 2010, Biochimica et biophysica acta.

[7]  E. Delikatny,et al.  Phenylbutyrate induces apoptosis and lipid accumulations via a peroxisome proliferator‐activated receptor gamma‐dependent pathway , 2010, NMR in biomedicine.

[8]  N. deSouza,et al.  Detection of cancer in cervical tissue biopsies using mobile lipid resonances measured with diffusion‐weighted 1H magnetic resonance spectroscopy , 2010, NMR in biomedicine.

[9]  F. Howe,et al.  Correlations between in vivo 1H MRS and ex vivo 1H HRMAS metabolite measurements in adult human gliomas , 2010, Journal of magnetic resonance imaging : JMRI.

[10]  T. Floyd,et al.  Detection of lactate with a hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD‐SelMQC‐CSI) on a clinical MRI scanner: Application to tumors and muscle ischemia , 2009, Magnetic resonance in medicine.

[11]  J R Griffiths,et al.  Pattern recognition of MRSI data shows regions of glioma growth that agree with DTI markers of brain tumor infiltration , 2009, Magnetic resonance in medicine.

[12]  P. Stattin,et al.  Detection of polyunsaturated omega-6 fatty acid in human malignant prostate tissue by 1D and 2D high-resolution magic angle spinning NMR spectroscopy , 2009, Magnetic Resonance Materials in Physics, Biology and Medicine.

[13]  K. Uğurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T , 2009, Magnetic resonance in medicine.

[14]  V. Torchilin,et al.  1H NMR detection of mobile lipids as a marker for apoptosis: the case of anticancer drug-loaded liposomes and polymeric micelles. , 2009, Molecular pharmaceutics.

[15]  E. Furth,et al.  In vivo assessment of hepatic triglycerides in murine non-alcoholic fatty liver disease using magnetic resonance spectroscopy. , 2009, Biochimica et biophysica acta.

[16]  J. Permert,et al.  Increased lipid metabolism and cell turnover of MiaPaCa2 cells induced by high-fat diet in an orthotopic system. , 2009, Metabolism: clinical and experimental.

[17]  J. Borén,et al.  Lipid droplets as dynamic organelles connecting storage and efflux of lipids. , 2009, Biochimica et biophysica acta.

[18]  Y. Ohsaki,et al.  Biogenesis of cytoplasmic lipid droplets: from the lipid ester globule in the membrane to the visible structure. , 2009, Biochimica et biophysica acta.

[19]  H. Robenek,et al.  Compartmentalization of proteins in lipid droplet biogenesis. , 2009, Biochimica et biophysica acta.

[20]  M. Welte,et al.  PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. , 2009, Biochimica et biophysica acta.

[21]  R. Kauppinen,et al.  Monitoring of gliomas in vivo by diffusion MRI and 1H MRS during gene therapy‐induced apoptosis: interrelationships between water diffusion and mobile lipids , 2009, NMR in biomedicine.

[22]  J. Balsinde,et al.  Lipid Droplet Biogenesis Induced by Stress Involves Triacylglycerol Synthesis That Depends on Group VIA Phospholipase A2* , 2009, Journal of Biological Chemistry.

[23]  Franklyn A Howe,et al.  An investigation of human brain tumour lipids by high‐resolution magic angle spinning 1H MRS and histological analysis , 2008, NMR in biomedicine.

[24]  M. Q. Huang,et al.  In vivo MRS markers of response to CHOP chemotherapy in the WSU‐DLCL2 human diffuse large B‐cell lymphoma xenograft , 2008, NMR in biomedicine.

[25]  S. Ylä-Herttuala,et al.  1H MR spectroscopic imaging of phospholipase‐mediated membrane lipid release in apoptotic rat glioma in vivo , 2008, Magnetic resonance in medicine.

[26]  Pietro Luigi Indovina,et al.  Metabolomics Using 1H-NMR of Apoptosis and Necrosis in HL60 Leukemia Cells: Differences between the Two Types of Cell Death and Independence from the Stimulus of Apoptosis Used , 2008, Radiation research.

[27]  J R Griffiths,et al.  Linear discriminant analysis of brain tumour 1H MR spectra: a comparison of classification using whole spectra versus metabolite quantification , 2007, NMR in biomedicine.

[28]  P. Brooks,et al.  Impact of the non‐cellular tumor microenvironment on metastasis: Potential therapeutic and imaging opportunities , 2007, Journal of cellular physiology.

[29]  T. Jeitner,et al.  Lovastatin enhances phenylbutyrate-induced MR-visible glycerophosphocholine but not apoptosis in DU145 prostate cells. , 2007, Biochimica et biophysica acta.

[30]  P. Maini,et al.  Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer , 2007, British Journal of Cancer.

[31]  M. Welte Proteins under new management: lipid droplets deliver. , 2007, Trends in cell biology.

[32]  T. Bathen,et al.  Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T , 2007, BMC Cancer.

[33]  P. Eliat,et al.  Nuclear Magnetic Resonance Spectroscopy of Lipids in Cancer , 2007 .

[34]  F A Howe,et al.  The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. , 2007, Clinical radiology.

[35]  T. Bathen,et al.  Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas , 2007, BMC Cancer.

[36]  Pietro Luigi Indovina,et al.  Temporal Dynamics of 1H-NMR-Visible Metabolites during Radiation-Induced Apoptosis in MG-63 Human Osteosarcoma Spheroids , 2006, Radiation research.

[37]  Y. Liu,et al.  Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer , 2006, Prostate Cancer and Prostatic Diseases.

[38]  M. Ala-Korpela,et al.  Identification of mobile cholesterol compounds in experimental gliomas by 1H MRS in vivo: Effects of ganciclovir‐induced apoptosis on lipids , 2006, FEBS letters.

[39]  I. Tkáč,et al.  Ultra‐short echo time spectroscopic imaging in rats: implications for monitoring lipids in glioma gene therapy , 2006, NMR in biomedicine.

[40]  K. Takakura,et al.  Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases , 2006, Brain Tumor Pathology.

[41]  Pietro Luigi Indovina,et al.  Increases in 1H-NMR Mobile Lipids are not Always Associated with Overt Apoptosis: Evidence from MG-63 Human Osteosarcoma Three-Dimensional Spheroids Exposed to a Low Dose (2 Gy) of Ionizing Radiation , 2006, Radiation research.

[42]  C. Spenger,et al.  Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations. , 2005, Cancer letters.

[43]  Jonathan E. Schmitz,et al.  1H MRS‐visible lipids accumulate during apoptosis of lymphoma cells in vitro and in vivo , 2005, Magnetic resonance in medicine.

[44]  Toshinori Hirai,et al.  Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. , 2005, AJNR. American journal of neuroradiology.

[45]  D. Samid,et al.  Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells. , 2005, Biochimica et biophysica acta.

[46]  G. Sevlever,et al.  Characterization of brain tumors by MRS, DWI and Ki-67 labeling index , 2005, Journal of Neuro-Oncology.

[47]  Edward J. Wood,et al.  Biochemistry (3rd ed.) , 2004 .

[48]  Peter Andersen,et al.  Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 T , 2004, Magnetic resonance in medicine.

[49]  F. Howe,et al.  Differentiation of metastases from high‐grade gliomas using short echo time 1H spectroscopy , 2004, Journal of magnetic resonance imaging : JMRI.

[50]  C. Mountford,et al.  Proton MRS can determine the pathology of human cancers with a high level of accuracy. , 2004, Chemical reviews.

[51]  Z. Bhujwalla,et al.  Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer , 2004, Cancer Research.

[52]  G. Rustin,et al.  Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome , 2004, British Journal of Cancer.

[53]  T. Nakada,et al.  Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging. , 2004, Journal of neurosurgery.

[54]  I. Cox,et al.  Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study , 2004, NMR in biomedicine.

[55]  P. Barone,et al.  1H MRS studies of signals from mobile lipids and from lipid metabolites: comparison of the behavior in cultured tumor cells and in spheroids , 2004, NMR in biomedicine.

[56]  I. Cox,et al.  1H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: In vivo–ex vivo profiles and effect of tumor load , 2004, Journal of magnetic resonance imaging : JMRI.

[57]  C. Eskey,et al.  Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. , 2004, AJNR. American journal of neuroradiology.

[58]  I. Cox,et al.  1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration , 2004, NMR in biomedicine.

[59]  D. Mikulis,et al.  Diffusion-weighted imaging and single-voxel MR spectroscopy in a case of malignant cerebral lymphoma , 2003, Neuroradiology.

[60]  F. Podo,et al.  Triacsin C inhibits the formation of 1H NMR-visible mobile lipids and lipid bodies in HuT 78 apoptotic cells. , 2003, Biochimica et biophysica acta.

[61]  S. Brammah,et al.  Inhibition of tetraphenylphosphonium-induced NMR-visible lipid accumulation in human breast cells by chlorpromazine. , 2003, Biochimica et biophysica acta.

[62]  Uwe Himmelreich,et al.  Pathologic characterization of human prostate tissue with proton MR spectroscopy. , 2003, Radiology.

[63]  R. Kauppinen,et al.  Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death. , 2003, Cancer research.

[64]  M. Décorps,et al.  Correlation between the occurrence of 1H‐MRS lipid signal, necrosis and lipid droplets during C6 rat glioma development , 2003, NMR in biomedicine.

[65]  M. Hartmann,et al.  Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy , 2003, Neuroscience Letters.

[66]  U. Himmelreich,et al.  Detergent-resistant membrane fractions contribute to the total 1H NMR-visible lipid signal in cells. , 2003, European journal of biochemistry.

[67]  F. Podo,et al.  Two-step formation of 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells. , 2003, Biochemical pharmacology.

[68]  Carles Arús,et al.  Proton magnetic resonance spectroscopy (1H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization , 2003, European Radiology.

[69]  A. Knijn,et al.  High-resolution proton NMR measures mobile lipids associated with Triton-resistant membrane domains in haematopoietic K562 cells lacking or expressing caveolin-1 , 2003, European Biophysics Journal.

[70]  C. Arús,et al.  Measurement by nuclear magnetic resonance diffusion of the dimensions of the mobile lipid compartment in C6 cells. , 2002, Cancer research.

[71]  David Hearshen,et al.  Correlations between Magnetic Resonance Spectroscopy and Image-guided Histopathology, with Special Attention to Radiation Necrosis , 2002, Neurosurgery.

[72]  D. Cory,et al.  Biochemical correlates of thiazolidinedione‐induced adipocyte differentiation by high‐resolution magic angle spinning NMR spectroscopy , 2002, Magnetic resonance in medicine.

[73]  M O Leach,et al.  Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells , 2002, British Journal of Cancer.

[74]  D. Rideout,et al.  Nuclear magnetic resonance-visible lipids induced by cationic lipophilic chemotherapeutic agents are accompanied by increased lipid droplet formation and damaged mitochondria. , 2002, Cancer research.

[75]  N. King,et al.  Autologous lymphocyte-monocyte co-culture increases NMR-visible and cytoplasmic lipids in the absence of increased markers of lymphocyte activation. , 2001, Biochimica et biophysica acta.

[76]  D. Murphy The biogenesis and functions of lipid bodies in animals, plants and microorganisms. , 2001, Progress in lipid research.

[77]  D. Rideout,et al.  1H NMR visible lipids are induced by phosphonium salts and 5‐fluorouracil in human breast cancer cells , 2001, Magnetic resonance in medicine.

[78]  K. Nicolay,et al.  Diffusion NMR spectroscopy , 2001, NMR in biomedicine.

[79]  P. Indovina,et al.  The relationship between 1H-NMR mobile lipid intensity and cholesterol in two human tumor multidrug resistant cell lines (MCF-7 and LoVo). , 2001, Biochimica et biophysica acta.

[80]  M. Décorps,et al.  In vivo measurement of the size of lipid droplets in an intracerebral glioma in the rat , 2001, Magnetic resonance in medicine.

[81]  T. Bezabeh,et al.  Detection of drug-induced apoptosis and necrosis in human cervical carcinoma cells using 1H NMR spectroscopy , 2001, Cell Death and Differentiation.

[82]  C. Gasparovic,et al.  Mobile lipid production after confluence and pH stress in perfused C6 cells , 2001, NMR in biomedicine.

[83]  A. Stringaro,et al.  1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells. , 2001, Biochimica et biophysica acta.

[84]  R. Kauppinen,et al.  1H NMR visible lipids in the life and death of cells. , 2000, Trends in biochemical sciences.

[85]  F. Podo Tumour phospholipid metabolism , 1999, NMR in biomedicine.

[86]  Risto A. Kauppinen,et al.  1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: Implications for the in vivo detection of apoptosis , 1999, Nature Medicine.

[87]  P. Matarrese,et al.  1H‐MRS lipid signal modulation and morphological and ultrastructural changes related to tumor cell proliferation , 1999, Magnetic resonance in medicine.

[88]  A. Stringaro,et al.  Biophysical and structural characterization of 1H-NMR-detectable mobile lipid domains in NIH-3T3 fibroblasts. , 1999, Biochimica et biophysica acta.

[89]  G Johnson,et al.  Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.

[90]  I Barba,et al.  The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. , 1999, Cancer research.

[91]  R. Kauppinen,et al.  Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. , 1998, Cancer research.

[92]  O. Kizu,et al.  Application of proton chemical shift imaging in monitoring of gamma knife radiosurgery on brain tumors. , 1998, Magnetic resonance imaging.

[93]  D. Rideout,et al.  Induction of magnetic resonance‐visible lipid in a transformed human breast cell line by tetraphenylphosphonium chloride , 1997, International journal of cancer.

[94]  J. Smirniotopoulos,et al.  Primary central nervous system lymphoma: radiologic-pathologic correlation. , 1997, Radiographics : a review publication of the Radiological Society of North America, Inc.

[95]  G. King,et al.  The Generation of1H-NMR-Detectable Mobile Lipid in Stimulated Lymphocytes: Relationship to Cellular Activation, the Cell Cycle, and Phosphatidylcholine-Specific Phospholipase C , 1997 .

[96]  T. Jeitner,et al.  The accumulation of H-1 MR-visible lipid in human glioma cells is independent of the cell cycle. , 1997, International journal of oncology.

[97]  W. Mackinnon,et al.  Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. , 1997, Radiology.

[98]  R L Somorjai,et al.  The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. , 1997, Cancer research.

[99]  M. Garg,et al.  Increased saturated triacylglycerol levels in plasma membranes of human neutrophils stimulated by lipopolysaccharide. , 1997, Journal of lipid research.

[100]  G. Millot,et al.  Lipid signals detected by NMR proton spectroscopy of whole cells are not correlated to lipid droplets evidenced by the Nile red staining. , 1997, Cellular and molecular biology.

[101]  A. Molinari,et al.  Lower levels of 1H MRS-visible mobile lipids in H-ras transformed tumorigenic fibroblasts with respect to their untransformed parental cells. , 1997, Cellular and molecular biology.

[102]  F. Blankenberg,et al.  Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. , 1997, Blood.

[103]  A Moreno,et al.  Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. , 1997, Cancer research.

[104]  W. Mackinnon,et al.  A proton magnetic resonance spectroscopy study of aging and transformed human fibroblasts , 1996, Experimental Gerontology.

[105]  G. King,et al.  1H-NMR visible neutral lipids in activated T lymphocytes: relationship to phosphatidylcholine cycling. , 1996, Biochimica et biophysica acta.

[106]  L. Le Moyec,et al.  Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line. , 1996, Cancer research.

[107]  C. Mountford,et al.  Tetraphenylphosphonium chloride induced mr‐visible lipid accumulation in a malignant human breast cell line , 1996, International journal of cancer.

[108]  C. Mountford,et al.  Chemical Shift Imaging of Human Colorectal Tissue (Ex Vivo) , 1996, NMR in biomedicine.

[109]  G. Sutherland,et al.  Mobile lipid accumulation in necrotic tissue of high grade astrocytomas. , 1996, Anticancer research.

[110]  C E Mountford,et al.  Human cancers detected by proton MRS and chemical shift imaging ex vivo. , 1996, Anticancer research.

[111]  F. Blankenberg,et al.  Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. , 1996, Blood.

[112]  C. Mountford,et al.  Modulation of MR‐visible mobile lipid levels by cell culture conditions and correlations with chemotactic response , 1996, International journal of cancer.

[113]  Negendank Wg MR spectroscopy of musculoskeletal soft-tissue tumors. , 1995 .

[114]  U. Bogdahn,et al.  1H NMR investigations of tumor spheroids grown from a human glioma biopsy or from a human malignant glioma cell line. , 1995, Journal of magnetic resonance. Series B.

[115]  H. Poptani,et al.  Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. , 1995, AJNR. American journal of neuroradiology.

[116]  P. V. van Zijl,et al.  Single-scan in vivo lactate editing with complete lipid and water suppression by selective multiple-quantum-coherence transfer (Sel-MQC) with application to tumors. , 1995, Journal of magnetic resonance. Series B.

[117]  A. Kuesel,et al.  1H MR visible lipids in colon tissue from normal and carcinogen‐treated rats , 1995, NMR in biomedicine.

[118]  W. Mackinnon,et al.  Correlation of cellular differentiation in human colorectal carcinoma and adenoma cell lines with metabolite profiles determined by 1H magnetic resonance spectroscopy , 1994, International journal of cancer.

[119]  W. Mackinnon,et al.  Characterization of human ovarian epithelial tumors (ex vivo) by proton magnetic resonance spectroscopy , 1994, International Journal of Gynecologic Cancer.

[120]  D. Shungu,et al.  Band‐selective spin echoes for in vivo localized 1H NMR spectroscopy , 1994, Magnetic resonance in medicine.

[121]  G. Sutherland,et al.  Mobile lipids and metabolic heterogeneity of brain tumours as detectable by Ex Vivo 1H MR spectroscopy , 1994, NMR in biomedicine.

[122]  Ian C. P. Smith,et al.  1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.

[123]  A Haase,et al.  High‐resolution one‐and two‐dimensional 1H MRS of human brain tumor and normal glial cells , 1994, NMR in biomedicine.

[124]  N. King,et al.  1H magnetic resonance spectroscopy of primary human and murine cells of the myeloid lineage. , 1994, ImmunoMethods.

[125]  G. King,et al.  Two-dimensional 1H NMR studies of membrane changes during the activation of primary T lymphocytes. , 1994, ImmunoMethods.

[126]  C E Mountford,et al.  Proton magnetic resonance and human thyroid neoplasia. I: Discrimination between benign and malignant neoplasms. , 1994, The American journal of medicine.

[127]  T. Sorrell,et al.  The presence of cytoplasmic lipid droplets is not sufficient to account for neutral lipid signals in the 1H spectra of neutrophils , 1994, Magnetic resonance in medicine.

[128]  M. Décorps,et al.  In Vivo, Ex Vivo, and In Vitro One‐ and Two‐Dimensional Nuclear Magnetic Resonance Spectroscopy of an Intracerebral Glioma in Rat Brain: Assignment of Resonances , 1994, Journal of neurochemistry.

[129]  C. Mountford,et al.  Assessment of human colorectal biopsies by 1H MRS: Correlation with histopathology , 1993, Magnetic resonance in medicine.

[130]  C. Mountford,et al.  Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. , 1993, Radiology.

[131]  K. Brindle,et al.  The appearance of neutral lipid signals in the 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets , 1993, Magnetic resonance in medicine.

[132]  C. Arús,et al.  1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance , 1993, NMR in biomedicine.

[133]  L. Le Moyec,et al.  Cell and membrane lipid analysis by proton magnetic resonance spectroscopy in five breast cancer cell lines. , 1992, British Journal of Cancer.

[134]  G. King,et al.  An NMR investigation of the changes in plasma membrane triglyceride and phospholipid precursors during the activation of T-lymphocytes. , 1992, Biochemistry.

[135]  W. Mackinnon,et al.  Esterified cholesterol and triglyceride are present in plasma membranes of Chinese hamster ovary cells. , 1992, European journal of biochemistry.

[136]  N. King,et al.  Magnetic resonance studies of murine macrophages , 1991, FEBS letters.

[137]  V. Viti,et al.  Interaction of HIV‐1 with susceptible lymphoblastoid cells 1H NMR studies , 1991, FEBS letters.

[138]  C. Mountford,et al.  Identification of triglyceride in malignant cells , 1991 .

[139]  C. Mountford,et al.  Comparison of human polymorphonuclear leukocytes from peripheral blood and purulent exudates by high resolution 1H MRS , 1991, Magnetic resonance in medicine.

[140]  C. Sotak Multiple quantum NMR spectroscopy methods for measuring the apparent self‐diffusion coefficient of In Vivo lactic acid , 1991, NMR in biomedicine.

[141]  N. Hunt,et al.  Development of the “activated” high resolution 1H MR spectrum in murine T cells and B cells occurs in G1 phase of the cell cycle , 1990, Magnetic resonance in medicine.

[142]  V. Bertone,et al.  Histochemical probes for the detection of hypoxic tumour cells. , 1990, Anticancer research.

[143]  W. Mackinnon,et al.  Uterine cervical punch biopsy specimens can be analyzed by 1h mrs , 1990, Magnetic resonance in medicine.

[144]  W. Mackinnon,et al.  Further evidence that the narrow 1H magnetic resonance signals from malignant cells do not arise from intracellular lipid droplets , 1989, NMR in biomedicine.

[145]  P. Bottomley Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[146]  R Tischler,et al.  MR imaging using stimulated echoes (STEAM). , 1986, Radiology.

[147]  P. Wright,et al.  Assignment of acyl chain resonances from membranes of mammalian cells by two-dimensional NMR methods. , 1984, Biochemistry.

[148]  W. Mackinnon,et al.  NMR methods for characterizing the state of the surfaces of complex mammalian cells. , 1984, Journal of biochemical and biophysical methods.

[149]  R M Fox,et al.  Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy. , 1982, Cancer research.

[150]  C. Nicolau,et al.  1-H and 13-C nuclear magnetic resonance spectra of the lipids in normal and SV 40 virus-transformed hamster embryo fibroblast membranes. , 1975, Biochimica et biophysica acta.

[151]  N. Niles Pathologic Basis of Disease , 1974 .

[152]  J. A. Hamilton,et al.  Natural Abundance Carbon-13 Nuclear Magnetic Resonance Spectra of the Canine Sciatic Nerve , 1973, Science.

[153]  C. Arús,et al.  A possible cellular explanation for the NMR-visible mobile lipid (ML) changes in cultured C6 glioma cells with growth. , 2007, Biochimica et biophysica acta.

[154]  Robert G. Parton,et al.  Opinion: Lipid droplets: a unified view of a dynamic organelle , 2006, Nature Reviews Molecular Cell Biology.

[155]  T. Sorrell,et al.  The origin of 1H NMR-visible triacylglycerol in human neutrophils. Highfatty acid environments result in preferential sequestration of palmitic acid into plasma membrane triacylglycerol. , 2000, European journal of biochemistry.

[156]  F Ståhlberg,et al.  Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. , 2000, AJNR. American journal of neuroradiology.

[157]  G. King,et al.  The generation of 1H-NMR-detectable mobile lipid in stimulated lymphocytes: relationship to cellular activation, the cell cycle, and phosphatidylcholine-specific phospholipase C. , 1997, Biochemical and biophysical research communications.

[158]  W. Negendank MR spectroscopy of musculoskeletal soft-tissue tumors. , 1995, Magnetic resonance imaging clinics of North America.

[159]  H. Poptani,et al.  Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis. , 1995, Magnetic resonance imaging.

[160]  A. Banerji,et al.  Proton MRS similarity between central nervous system non-Hodgkin lymphoma and intracranial tuberculoma. , 1995, Magnetic resonance imaging.

[161]  Thomas L Chenevert,et al.  Magnetic Resonance Imaging and Spectroscopy: Application to Experimental Neuro-Oncology. , 1994, Quarterly of magnetic resonance in biology and medicine.

[162]  Keith R.F. Elliott,et al.  Biochemistry, 3rd edn , 1990 .

[163]  S. Robbins,et al.  Pathologic basis of disease , 1974 .